Skip to main content Accessibility help
  • This chapter is unavailable for purchase
  • Print publication year: 2010

105 - Valproic acid

Suggested Reading
Apostol, G, Cady, RK, Laforet, GA, Robieson, WZ, Olson, E, Abi-Saab, WM, Saltarelli, M. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache 2008;48(7):1012–25.
Cohen, AS, Matharu, MS, Goadsby, PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache 2007;47(6):969–80.
Limdi, NA, Knowlton, RK, Cofield, SS, Ver Hoef, LW, Paige, AL, Dutta, S, Faught, E. Safety of rapid intravenous loading of valproate. Epilepsia 2007;48(3):478–83.
Mackay, MT, Weiss, SK, Adams-Webber, T, Ashwal, S, Stephens, D, Ballaban-Gill, K, Baram, TZ, Duchowny, M, Hirtz, D, Pellock, JM, Shields, WD, Shinnar, S, Wyllie, E, Snead, OC; ,American Academy of Neurology; ,Child Neurology Society. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62(10):1668–81.
Posner, EB, Mohamed, K, Marson, AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2005;(4):CD003032.
Rauchenzauner, M, Haberlandt, E, Scholl-Bürgi, S, Ernst, B, Hoppichler, F, Karall, D, Ebenbichler, CF, Rostasy, K, Luef, G. Adiponectin and visfatin concentrations in children treated with valproic acid. Epilepsia 2008;49(2):353–7.
Silberstein, SD. Preventive migraine treatment. Neurol Clin 2009;27(2):429–43.
Swoboda, KJ, Scott, CB, Reyna, SP, Prior, TW, LaSalle, B, Sorenson, SL, Wood, J, Acsadi, G, Crawford, TO, Kissel, JT, Krosschell, KJ, D'Anjou, G, Bromberg, MB, Schroth, MK, Chan, GM, Elsheikh, B, Simard, LR. Phase II open label study of valproic acid in spinal muscular atrophy. PLoS One 2009;4(5):e5268.
Trinka, E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia 2007;48 (Suppl 8): 49–51.